BD Interlink threaded lock cannula This is a locking blunt plastic cannula specifically designed...
FDA Device Recall #Z-0772-2014 — Class II — November 26, 2013
Recall Summary
| Recall Number | Z-0772-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 26, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton Dickinson & Company |
| Location | Franklin Lakes, NJ |
| Product Type | Devices |
| Quantity | 268,500 products |
Product Description
BD Interlink threaded lock cannula This is a locking blunt plastic cannula specifically designed for IV connection to an Interlink¿ injection site. It is screwed down over the Interlink¿ injection site and a blunt plastic cannula inside the housing enters the Interlink¿ injection site to provide a pathway for IV fluid administration.
Reason for Recall
BD Interlink Threaded Lock Cannula REF# 303369 and lot #3021392 is being recalled due to the potential that a small percentage of the lot may exhibit open seals which adversely impacts unit package integrity and product sterility.
Distribution Pattern
Worldwide Distribution - USA (nationwide) and Internationally to Canada and Japan.
Lot / Code Information
Marketing Status: Class II, 510K # K011858 Device Listing Number: D043644 Lot number 3021392
Other Recalls from Becton Dickinson & Company
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2257-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
| Z-2249-2026 | Class I | BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.... | Apr 27, 2026 |
| Z-2251-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3... | Apr 27, 2026 |
| Z-2255-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
| Z-2256-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.